Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Masonic Cancer Center, University of Minnesota
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
NF1 diagnosis based on NIH Consensus Conference Criteria and/or genetic testing
Measurable cutaneous neurofibromas (cNFs) with or without plexiform NF
Aged 18 years or older at the time of written consent
Voluntary signed written consent obtained before the performance of any study-related procedure not part of normal medical care
You may not be if
Concurrent treatment with selumetinib or other MAPK, MEK or mTOR inhibitors, other targeted therapies, chemotherapy or radiation
Conditions requiring systemic immunosuppression
Swallowing difficulties or strong gag reflex which may interfere with study compliance
Any comorbidities that may affect study participation in the judgement of enrolling investigator
Psychiatric illness, cognitive challenges, social situations, or other circumstances that would limit compliance with study requirements, per judgment of the enrolling investigator
Treatment with high phenolic olive oil or curcumin within six months of study entry
Known pregnancy or anticipated conception during the 1 year study period